April 24, 2012

Cover Story

CEO of the Year

Utah’s business landscape is rich with professionals who have le...Read More

Featured Articles

Did you go Skiing this winter?

Around Utah

Sections

Spotlight
Martin Plaehn

Spotlight
Karen Sendelback

Legal Briefs
Social Media and Employers: Friends or Enemies?

Money Talk
The Case for HSAs

Economic Insight
Time to Show Up

Lessons Learned
Make a Move

TechKnowledge
In the Lab

EntrepreneurEdge
Rent to Own

Business Trends
Back from the Dead

Executive Living
Artful Inspiration

Features
A Breath of Fresh Air

Features
Worst-Case Scenario

Regional Report
Northern Utah

Focus
Measure Up

Industry Outlook
Travel & Tourism

Players
Players

Article

BSD Medical Announces Study Featuring MicroThermX Microwave Ablation System

Press Release

April 24, 2012

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, announced that a scientific poster presented at the Society of Interventional Radiology (SIR) conference, featuring data generated using the MicroThermX Microwave Ablation System (MicroThermX), demonstrated a significant advantage for MicroThermX microwave ablation. The study, ‘Impact of Variation in Portal Venous Blood Flow on the Size of Radiofrequency and Microwave Ablation Lesions,’ was conducted by Gerald D. Dodd, III, MD, Nicolas A. Dodd, and Anthony C. Lanctot, MS, Department of Radiology, University of Colorado, School of Medicine. Dodd, one of the pioneers in Radiofrequency (RF) ablation, presented the data from the in-vitro study, which was designed to assess the impact of variations in blood flow on ablation zones produced using the microwave MicroThermX compared to a commercially available RF system. The presentation received an award at the SIR conference.

"Microwave ablation is able to deliver a predictable and reproducible heating pattern that is not influenced by physiological changes in blood flow in the liver," said Dodd. "This is a significant clinical advantage over RF ablation, which is significantly impacted by physiological changes in blood flow in the liver. Predictable and reproducible ablations are a critical element of treatment planning for ablation. Not knowing the size of the ablation that you are going to get when treating a liver tumor leads to both over-treatment and under-treatment. Over-treatment poses the risk of injury to adjacent vital structures, and under-treatment means you didn't 'kill' the tumor. The predictable and reproducible performance of microwave ablation should translate to improved clinical results for cancer patients."
(4.24.12)

Utah Business Social
UB Events View All
Community Events View All
Used Car Show in - Salt lake City - Clearfield in September
Sep 1, 2014
Visit Us at Our Two Location's We have Show of Old Cars, New Cars, used Cars. You Can Exchange or...
Banking on Women™ Program
Sep 4, 2014
Westminster Seeks Female Entrepreneurs for Free Training Program Revolutionary Banking on Women™...

info@utahbusiness.com  |  90 South 400 West, Ste 650 Salt Lake City, Utah 84101   |  (801) 568-0114

Advertise with Utah Business

Submit an Event

* indicates required information
* Event Name:
Price (general):
Website (if applicable):
Coordinator's Name:
Coordinator's Email:
Coordinator's Phone:
Venue Name:
Venue Address:
Venue City:
Venue Zip:
Event Capacity:
Date(s):
to
* Event Description:
  Cancel